Based on target expression profiles, αDC1-EphA2 likely mediated specific immune responses against both MC38 tumor cells (Supplementary Figure 1B) and tumor-derived endothelial cells to provide maximum modeling protection (7). Here, EPHA2 is linked to neoplasm.